Latest News

Axovia Therapeutics receives grant from A Race Against Blindness to support upcoming clinical trial
Axovia Therapeutics receives grant from A Race Against Blindness to support upcoming clinical trial

February 11th 2025

The trial will feature the company’s product candidate, AXV101, focused on combating childhood blindness due to retinitis pigmentosa (RP) caused by Bardet-Biedl Syndrome 1 (BBS1).

Bausch + Lomb provides update on potential sale
Bausch + Lomb provides update on potential sale

February 11th 2025

4DMT announces positive 52-week data from phase 2b cohort of PRISM wet AMD study
4DMT announces positive 52-week data from phase 2b cohort of PRISM wet AMD study

February 10th 2025

Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg

February 10th 2025

Expert Insights: Ramiro Ribeiro, MD, PhD, discusses next steps in EYP-1901 research
Expert Insights: Ramiro Ribeiro, MD, PhD, discusses next steps in EYP-1901 research

February 8th 2025

Latest Videos

Latest News

© 2025 MJH Life Sciences

All rights reserved.